CHIMERA INVESTMENT CORP - 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Chimera Investment Corporation on May 15, 2024, reporting a material definitive agreement entered into on the same date. The Company is a Maryland corporation with its principal executive offices in New York, New York.
Key Financial Metrics and Transaction Details
The filing details a new debt issuance rather than periodic financial performance metrics such as revenue or cash flow.
- Instrument: 9.000% Senior Notes due 2029.
- Aggregate Principal Amount: $65 million.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional $9.75 million.
- Closing Date: Scheduled for May 22, 2024, subject to customary conditions.
- Underwriters: Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, UBS Securities LLC, Wells Fargo Securities, LLC, Keefe, Bruyette & Woods, Inc., and Piper Sandler & Co.
Material Changes
The filing does not provide comparative financial data against prior periods. The material change is the entry into a new underwriting agreement to raise capital through the issuance of senior notes.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard representations and indemnification clauses within the Underwriting Agreement. The transaction is subject to customary closing conditions.
Key Facts for Investor Verification
- Verify the final closing of the $65 million offering on or around May 22, 2024.
- Confirm whether the underwriters exercised the $9.75 million over-allotment option.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific covenants and use of proceeds.
- Check subsequent filings for the impact of this new debt on the Company's leverage ratios and liquidity position.